Your Article Summary
Targeted Genetics Realigns Product Development Priorities and Implements Cost Reduction Measures
Corporate News Releases - The Healthcare Sales & Marketing Network, 12/03/08
Targeted Genetics Corporation announced that it has realigned its product development priorities to focus on its ocular and neurological product candidates and its first use of expressed RNAi. The Company believes these candidates present the greatest opportunity for creating value in the near term with the capabilities and resources currently available to the Company and its collaborators and with the financial resources it believes are available in today's challenging capital markets.
Today in Research & Development...keeping you current
Receive free subspecialty "5-minute updates" via email
GSK Update: GSKs Arepanrix H1N1 pandemic vaccine prequalified by the World Health Organization
GlaxoSmithKline, 12/02/09
Bayer Schering Pharma to collaborate with Micromet on novel approach to cancer therapy
BayNews International, 12/02/09
Complete Genomics and GATC Biotech Collaborate on Human Genome Sequencing Projects
b3c newswire, 12/02/09
Article Search
Sponsor


See Latest Articles


